Mitral Valve Organ Culture Provides a Novel Experimental Paradigm

Date
2011
Journal Title
Journal ISSN
Volume Title
Publisher
Description
Abstract

Mitral valve diseases and disorders affect tens of thousands of Americans each year, but understanding of the disease processes has yet to be fully developed. The behavior and characteristics of valve cells and tissue are highly dependent on their surrounding environment, including neighboring cells, extracellular matrix composition and 3D structure, mechanical forces, and signaling molecules both in the tissue and the circulation. In order to study native valve behavior and responses, an ex vivo bioreactor system was developed to culture whole mitral valves. The organ culture system simulated a physiologically relevant mechanical environment and provided nutrients and gas exchange. Valves cultured in this dynamic system retained more native cell and tissue characteristics than valves cultured in a static environment. To utilize this novel tool, a study was conducted to determine the effects of Angiotensin II on mitral valves, alone and in combination with the statin drug, Simvastatin.Angiotensin II was found to alter the native valve composition. Simvastatin inhibited some of these alterations, but accentuated others and also affected separate valve characteristics. In conclusion, an organ culture system for mitral valves has been designed, characterized, validated, and effectively put to use in a novel study.

Description
Degree
Doctor of Philosophy
Type
Thesis
Keywords
Engineering, Biomedical engineering
Citation

Gheewala, Nikhil. "Mitral Valve Organ Culture Provides a Novel Experimental Paradigm." (2011) Diss., Rice University. https://hdl.handle.net/1911/64439.

Has part(s)
Forms part of
Published Version
Rights
Copyright is held by the author, unless otherwise indicated. Permission to reuse, publish, or reproduce the work beyond the bounds of fair use or other exemptions to copyright law must be obtained from the copyright holder.
Link to license
Citable link to this page